SC Hematology, AOU Città della Salute e della Scienza di Torino

The trials here

What the 2 trials at this site are about, from their registry records.

Phase

• Phase 32 trials

Status

• Recruiting2 trials

Lead sponsor

• Regeneron Pharmaceuticals2 trials

Running trials

• Recruiting

  A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently

  NCT07154745· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

  NCT05744921· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator